Literature DB >> 22301402

Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer. A pilot prospective study.

Cristina Moretones1, David León, Arturo Navarro, Olalla Santacruz, Ana María Boladeras, Miquel Macià, María Cambray, Valentí Navarro, Ignasi Modolell, Ferran Guedea.   

Abstract

INTRODUCTION: The aim of this study is to determine the interobserver variability (IV) between radiation oncologists (RO) in target volume delineation for postoperative gastric cancer (GC) radiotherapy planning.
MATERIALS AND METHODS: Four physicians were asked to delimitate clinical target volume (CTV) on the same 3D CT images in 9 postoperative radiochemotherapy GC patients. Instructions were given to include tumour bed, remaining stomach, anastomosis, duodenal loop and local lymph nodes. The principal variable was spatial volume discrepancy between the main observer (called "A") and other observers (all called "B"), which were compared using the mathematical formula A⌣B/A⌢B, applied to the 3D CT images using Boolean operators. Analysis of variance with two random effects (observers and patients) was performed.
RESULTS: Mean volumes were 1410 cm(3) for OBA, 1231 cm(3) for OB2, 734.6 cm(3) for OB3 and 1350 cm(3) for OB4. Discrepancies were 519.9±431.6 cm(3) for OB2, 652.1±294.36 cm(3) for OB3 and 225.90±237.07 cm(3) for OB4. Standard deviation ascribed to patients as random effect was 898.6 cm(3) and that ascribed to observers was 198.10 cm(3), considered as a statistically significant difference.
CONCLUSIONS: A significant IV in target delineation that can be attributed to many factors depends more on patients' characteristics than RO delineating decisions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301402     DOI: 10.1007/s12094-012-0772-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  19 in total

1.  Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. A comparison between gynaecologic and radiation oncologists.

Authors:  Elisabeth Weiss; Susanne Richter; Thomas Krauss; Silke I Metzelthin; Andrea Hille; Olivier Pradier; Birgit Siekmeyer; Hilke Vorwerk; Clemens F Hess
Journal:  Radiother Oncol       Date:  2003-04       Impact factor: 6.280

Review 2.  The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences.

Authors:  Elisabeth Weiss; Clemens F Hess
Journal:  Strahlenther Onkol       Date:  2003-01       Impact factor: 3.621

3.  A new suggestion for the radiation target volume after a subtotal gastrectomy in patients with stomach cancer.

Authors:  Heerim Nam; Do Hoon Lim; Sung Kim; Won Ki Kang; Tae Sung Sohn; Jae Hyung Noh; Yong Il Kim; Chan Hyung Park; Chul Keun Park; Yong Chan Ahn; Seung Jae Huh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

4.  Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans.

Authors:  Giovanni Mauro Cattaneo; Michele Reni; Giovanna Rizzo; Pietro Castellone; Giovanni Luca Ceresoli; Cesare Cozzarini; Andrés José Maria Ferreri; Paolo Passoni; Riccardo Calandrino
Journal:  Radiother Oncol       Date:  2005-05       Impact factor: 6.280

5.  Variability in target volume delineation on CT scans of the breast.

Authors:  C W Hurkmans; J H Borger; B R Pieters; N S Russell; E P Jansen; B J Mijnheer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

6.  Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.

Authors:  Stephen R Smalley; Leonard Gunderson; Joel Tepper; James A Martenson; Bruce Minsky; Christopher Willett; Tyvin Rich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

7.  Variability of target volume delineation in cervical esophageal cancer.

Authors:  P Tai; J Van Dyk; E Yu; J Battista; L Stitt; T Coad
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

Review 8.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Authors:  Oscar Matzinger; Erich Gerber; Zvi Bernstein; Philippe Maingon; Karin Haustermans; Jean François Bosset; Akos Gulyban; Philip Poortmans; Laurence Collette; Abraham Kuten
Journal:  Radiother Oncol       Date:  2009-04-15       Impact factor: 6.280

9.  Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view.

Authors:  D H Lim; D Y Kim; M K Kang; Y I Kim; W K Kang; C K Park; S Kim; J H Noh; J W Joh; S H Choi; T S Sohn; J S Heo; C H Park; J O Park; J E Lee; Y J Park; H R Nam; W Park; Y C Ahn; S J Huh
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

10.  CT slice index and thickness: impact on organ contouring in radiation treatment planning for prostate cancer.

Authors:  E Berthelet; M Liu; P Truong; P Czaykowski; N Kalach; C Yu; K Patterson; T Currie; S Kristensen; W Kwan; V Moravan
Journal:  J Appl Clin Med Phys       Date:  2003       Impact factor: 2.102

View more
  3 in total

1.  Clinical target volume in postoperative radiotherapy for gastric cancer: identification of major difficulties and controversies.

Authors:  J Socha; G Wołąkiewicz; E Wasilewska-Teśluk; P Janiga; T Kondraciuk; A Majewska; K Olearski; L Kępka
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

2.  The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer.

Authors:  Cem Onal; Mustafa Cengiz; Ozan C Guler; Yemliha Dolek; Serdar Ozkok
Journal:  Br J Radiol       Date:  2017-03-24       Impact factor: 3.039

Review 3.  Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition.

Authors:  Jing Xu; Jonathan Zhu; Qichun Wei
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.